News Lucie Harper and Kate Hawker join W2O as global practice lea... W2O has appointed healthcare communications veterans Lucie Harper and Kate Hawker as global practice leaders, based at its London office.
News NICE backs first targeted therapy for ALK+ lung cancer Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.